| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity | 1.04e-05 | 7 | 135 | 3 | GO:0008467 | |
| GeneOntologyMolecularFunction | armadillo repeat domain binding | 2.46e-05 | 9 | 135 | 3 | GO:0070016 | |
| GeneOntologyMolecularFunction | [heparan sulfate]-glucosamine 3-sulfotransferase 3 activity | 4.54e-05 | 2 | 135 | 2 | GO:0033872 | |
| GeneOntologyMolecularFunction | gamma-catenin binding | 6.36e-05 | 12 | 135 | 3 | GO:0045295 | |
| GeneOntologyMolecularFunction | gated channel activity | CACNA1A GABRR1 GABRR2 ANO10 KCNH6 CLCN3 P2RX6 CNGB3 CACNA1G CACNG4 | 9.31e-05 | 334 | 135 | 10 | GO:0022836 |
| GeneOntologyMolecularFunction | heparan sulfate sulfotransferase activity | 1.30e-04 | 15 | 135 | 3 | GO:0034483 | |
| GeneOntologyMolecularFunction | low-density lipoprotein particle receptor activity | 1.59e-04 | 16 | 135 | 3 | GO:0005041 | |
| GeneOntologyMolecularFunction | monoatomic ion channel activity | CACNA1A GABRR1 GABRR2 ANO10 KCNH6 CLCN3 P2RX6 CNGB3 LRRC8A CACNA1G CACNG4 | 2.91e-04 | 459 | 135 | 11 | GO:0005216 |
| GeneOntologyMolecularFunction | lipoprotein particle receptor activity | 3.68e-04 | 21 | 135 | 3 | GO:0030228 | |
| GeneOntologyMolecularFunction | sulfotransferase activity | 5.22e-04 | 55 | 135 | 4 | GO:0008146 | |
| GeneOntologyMolecularFunction | dioxygenase activity | 5.38e-04 | 98 | 135 | 5 | GO:0051213 | |
| GeneOntologyMolecularFunction | monoatomic anion channel activity | 6.76e-04 | 103 | 135 | 5 | GO:0005253 | |
| GeneOntologyMolecularFunction | channel activity | CACNA1A GABRR1 GABRR2 ANO10 KCNH6 CLCN3 P2RX6 CNGB3 LRRC8A CACNA1G CACNG4 | 8.90e-04 | 525 | 135 | 11 | GO:0015267 |
| GeneOntologyMolecularFunction | passive transmembrane transporter activity | CACNA1A GABRR1 GABRR2 ANO10 KCNH6 CLCN3 P2RX6 CNGB3 LRRC8A CACNA1G CACNG4 | 9.04e-04 | 526 | 135 | 11 | GO:0022803 |
| GeneOntologyMolecularFunction | telomerase activity | 9.32e-04 | 7 | 135 | 2 | GO:0003720 | |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | CACNA1A GABRR1 GABRR2 ANO10 NDUFB9 SFXN1 KCNH6 CLCN3 P2RX6 CNGB3 LRRC8A SLC9A7 CACNA1G CACNG4 | 9.69e-04 | 793 | 135 | 14 | GO:0015075 |
| GeneOntologyMolecularFunction | 2-oxoglutarate-dependent dioxygenase activity | 9.83e-04 | 65 | 135 | 4 | GO:0016706 | |
| GeneOntologyMolecularFunction | volume-sensitive anion channel activity | 1.58e-03 | 9 | 135 | 2 | GO:0005225 | |
| GeneOntologyMolecularFunction | transferase activity, transferring sulphur-containing groups | 1.59e-03 | 74 | 135 | 4 | GO:0016782 | |
| GeneOntologyBiologicalProcess | heparan sulfate proteoglycan metabolic process | 3.80e-06 | 17 | 134 | 4 | GO:0030201 | |
| GeneOntologyBiologicalProcess | amyloid-beta clearance by transcytosis | 9.21e-06 | 7 | 134 | 3 | GO:0150093 | |
| GeneOntologyBiologicalProcess | transcytosis | 1.64e-05 | 24 | 134 | 4 | GO:0045056 | |
| GeneOntologyBiologicalProcess | circulatory system development | FOXM1 EEF1AKMT4-ECE2 TCF7L2 C1GALT1 LMO4 NEB FZD4 NPHP3 AGO1 EGF JMJD6 MTOR SULF1 GALNT11 VCAN TLR3 LRP1 LRP2 CACNA1G ASB4 TAB1 LEF1 TBX1 FOXJ1 | 1.77e-05 | 1442 | 134 | 24 | GO:0072359 |
| GeneOntologyBiologicalProcess | tube morphogenesis | FOXM1 TCF7 TCF7L2 C1GALT1 LMO4 FZD4 NPHP3 AGO1 EGF JMJD6 SULF1 TLR3 LRP1 LRP2 ASB4 HS3ST3B1 HS3ST3A1 CDH1 LEF1 TBX1 | 3.92e-05 | 1125 | 134 | 20 | GO:0035239 |
| GeneOntologyBiologicalProcess | proteoglycan metabolic process | 4.09e-05 | 97 | 134 | 6 | GO:0006029 | |
| GeneOntologyBiologicalProcess | heparan sulfate proteoglycan biosynthetic process | 7.63e-05 | 35 | 134 | 4 | GO:0015012 | |
| GeneOntologyBiologicalProcess | proteoglycan biosynthetic process | 9.26e-05 | 70 | 134 | 5 | GO:0030166 | |
| GeneOntologyBiologicalProcess | tube development | FOXM1 TCF7 TCF7L2 C1GALT1 LMO4 FZD4 NPHP3 AGO1 EGF JMJD6 SULF1 TLR3 LRP1 LRP2 ASB4 TAB1 HS3ST3B1 HS3ST3A1 CDH1 LEF1 TBX1 FOXJ1 | 9.96e-05 | 1402 | 134 | 22 | GO:0035295 |
| GeneOntologyBiologicalProcess | glycoprotein biosynthetic process | TCF7L2 C1GALT1 ST6GALNAC2 STT3A GALNT11 CHST12 HS3ST4 FUT5 HS3ST3B1 HS3ST3A1 | 1.16e-04 | 357 | 134 | 10 | GO:0009101 |
| GeneOntologyBiologicalProcess | glycoprotein metabolic process | TCF7L2 C1GALT1 ST6GALNAC2 STT3A SULF1 GALNT11 CHST12 HS3ST4 FUT5 HS3ST3B1 HS3ST3A1 | 1.18e-04 | 430 | 134 | 11 | GO:0009100 |
| GeneOntologyBiologicalProcess | response to nickel cation | 1.25e-04 | 3 | 134 | 2 | GO:0010045 | |
| GeneOntologyBiologicalProcess | amyloid-beta clearance | 1.30e-04 | 40 | 134 | 4 | GO:0097242 | |
| GeneOntologyBiologicalProcess | monoatomic anion transport | 1.96e-04 | 183 | 134 | 7 | GO:0006820 | |
| GeneOntologyBiologicalProcess | inorganic anion transmembrane transport | 2.44e-04 | 134 | 134 | 6 | GO:0098661 | |
| GeneOntologyBiologicalProcess | cardiac septum development | 2.44e-04 | 134 | 134 | 6 | GO:0003279 | |
| GeneOntologyBiologicalProcess | embryonic genitalia morphogenesis | 2.49e-04 | 4 | 134 | 2 | GO:0030538 | |
| GeneOntologyCellularComponent | Golgi membrane | EEF1AKMT4-ECE2 RAB11A C1GALT1 ST6GALNAC2 CLCN3 MBTPS2 MTOR GALNT11 TLR3 SLC9A7 CHST12 HS3ST4 FUT5 HS3ST3B1 HS3ST3A1 RIC1 | 1.57e-05 | 721 | 134 | 16 | GO:0000139 |
| GeneOntologyCellularComponent | Cul5-RING ubiquitin ligase complex | 2.99e-05 | 10 | 134 | 3 | GO:0031466 | |
| GeneOntologyCellularComponent | beta-catenin-TCF complex | 7.03e-05 | 13 | 134 | 3 | GO:1990907 | |
| GeneOntologyCellularComponent | voltage-gated calcium channel complex | 2.14e-04 | 46 | 134 | 4 | GO:0005891 | |
| GeneOntologyCellularComponent | postsynaptic membrane | CACNA1A GABRR1 GABRR2 GRM5 CLCN3 P2RX6 PTPRZ1 LRP1 CACNG4 CNTN1 | 2.88e-04 | 405 | 134 | 10 | GO:0045211 |
| GeneOntologyCellularComponent | phosphorylase kinase complex | 4.03e-04 | 5 | 134 | 2 | GO:0005964 | |
| GeneOntologyCellularComponent | endocytic vesicle membrane | 4.42e-04 | 212 | 134 | 7 | GO:0030666 | |
| GeneOntologyCellularComponent | monoatomic ion channel complex | CACNA1A GABRR1 GABRR2 CATSPERD KCNH6 CNGB3 LRRC8A CACNA1G CACNG4 | 7.54e-04 | 378 | 134 | 9 | GO:0034702 |
| GeneOntologyCellularComponent | glutamatergic synapse | CACNA1A GABRR1 RAB11A CHD4 GRM5 FZD4 CLCN3 P2RX6 MTOR PTPRZ1 LRP1 CACNG4 CDH1 CNTN1 | 7.74e-04 | 817 | 134 | 14 | GO:0098978 |
| GeneOntologyCellularComponent | recycling endosome membrane | 7.78e-04 | 112 | 134 | 5 | GO:0055038 | |
| GeneOntologyCellularComponent | endocytic vesicle | 8.42e-04 | 384 | 134 | 9 | GO:0030139 | |
| GeneOntologyCellularComponent | calcium channel complex | 1.25e-03 | 73 | 134 | 4 | GO:0034704 | |
| GeneOntologyCellularComponent | cell leading edge | 1.45e-03 | 500 | 134 | 10 | GO:0031252 | |
| GeneOntologyCellularComponent | perineuronal net | 1.77e-03 | 10 | 134 | 2 | GO:0072534 | |
| Domain | CTNNB1_binding | 1.31e-06 | 4 | 130 | 3 | PF08347 | |
| Domain | TCF/LEF | 1.31e-06 | 4 | 130 | 3 | IPR024940 | |
| Domain | CTNNB1-bd_N | 1.31e-06 | 4 | 130 | 3 | IPR013558 | |
| Domain | Ldl_recept_b | 2.13e-06 | 14 | 130 | 4 | PF00058 | |
| Domain | LDLRB | 2.13e-06 | 14 | 130 | 4 | PS51120 | |
| Domain | LY | 2.88e-06 | 15 | 130 | 4 | SM00135 | |
| Domain | LDLR_classB_rpt | 2.88e-06 | 15 | 130 | 4 | IPR000033 | |
| Domain | - | 7.20e-06 | 39 | 130 | 5 | 2.120.10.30 | |
| Domain | 6-blade_b-propeller_TolB-like | 1.65e-05 | 46 | 130 | 5 | IPR011042 | |
| Domain | Catenin_binding_dom | 4.65e-05 | 29 | 130 | 4 | IPR027397 | |
| Domain | - | 4.65e-05 | 29 | 130 | 4 | 4.10.900.10 | |
| Domain | GABAAa_rho_rcpt | 4.81e-05 | 2 | 130 | 2 | IPR008057 | |
| Domain | DUF5050 | 4.81e-05 | 2 | 130 | 2 | IPR032485 | |
| Domain | DUF5050 | 4.81e-05 | 2 | 130 | 2 | PF16472 | |
| Domain | Snx9_subfam | 1.44e-04 | 3 | 130 | 2 | IPR014536 | |
| Domain | BAR_3_WASP_bdg | 1.44e-04 | 3 | 130 | 2 | PF10456 | |
| Domain | Sorting_nexin_WASP-bd-dom | 1.44e-04 | 3 | 130 | 2 | IPR019497 | |
| Domain | LDLR_class-A_CS | 1.69e-04 | 40 | 130 | 4 | IPR023415 | |
| Domain | Ldl_recept_a | 2.68e-04 | 45 | 130 | 4 | PF00057 | |
| Domain | - | 2.92e-04 | 46 | 130 | 4 | 4.10.400.10 | |
| Domain | LDLRA_1 | 3.44e-04 | 48 | 130 | 4 | PS01209 | |
| Domain | LDrepeatLR_classA_rpt | 3.73e-04 | 49 | 130 | 4 | IPR002172 | |
| Domain | LDLa | 3.73e-04 | 49 | 130 | 4 | SM00192 | |
| Domain | LDLRA_2 | 3.73e-04 | 49 | 130 | 4 | PS50068 | |
| Domain | EGF_Ca-bd_CS | 5.84e-04 | 97 | 130 | 5 | IPR018097 | |
| Domain | EGF_CA | 6.41e-04 | 99 | 130 | 5 | PS01187 | |
| Domain | ASX_HYDROXYL | 6.71e-04 | 100 | 130 | 5 | PS00010 | |
| Domain | cEGF | 7.62e-04 | 26 | 130 | 3 | PF12662 | |
| Domain | cEGF | 7.62e-04 | 26 | 130 | 3 | IPR026823 | |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | 8.74e-04 | 106 | 130 | 5 | IPR000152 | |
| Domain | Cupin_4 | 9.87e-04 | 7 | 130 | 2 | PF08007 | |
| Domain | HMG_box_dom | 1.09e-03 | 65 | 130 | 4 | IPR009071 | |
| Domain | JMJC | 1.41e-03 | 32 | 130 | 3 | PS51184 | |
| Domain | JmjC_dom | 1.41e-03 | 32 | 130 | 3 | IPR003347 | |
| Domain | JmjC | 1.54e-03 | 33 | 130 | 3 | SM00558 | |
| Domain | EGF_CA | 1.64e-03 | 122 | 130 | 5 | SM00179 | |
| Domain | EGF-like_Ca-bd_dom | 1.76e-03 | 124 | 130 | 5 | IPR001881 | |
| Domain | EGF | 1.89e-03 | 126 | 130 | 5 | PF00008 | |
| Domain | Sulfotransfer_1 | 1.99e-03 | 36 | 130 | 3 | PF00685 | |
| Domain | Sulfotransferase_dom | 1.99e-03 | 36 | 130 | 3 | IPR000863 | |
| Domain | HAT | 2.09e-03 | 10 | 130 | 2 | SM00386 | |
| Domain | VDCCAlpha1 | 2.09e-03 | 10 | 130 | 2 | IPR002077 | |
| Domain | HAT | 2.09e-03 | 10 | 130 | 2 | IPR003107 | |
| Domain | EGF_CA | 3.06e-03 | 86 | 130 | 4 | PF07645 | |
| Domain | PX | 3.54e-03 | 44 | 130 | 3 | SM00312 | |
| Domain | PI3/4_kinase_CS | 4.76e-03 | 15 | 130 | 2 | IPR018936 | |
| Domain | PX | 4.81e-03 | 49 | 130 | 3 | PF00787 | |
| Domain | PX | 5.09e-03 | 50 | 130 | 3 | PS50195 | |
| Domain | - | 5.38e-03 | 51 | 130 | 3 | 3.30.1520.10 | |
| Domain | - | 5.41e-03 | 16 | 130 | 2 | 1.10.1070.11 | |
| Domain | PI3Kc | 5.41e-03 | 16 | 130 | 2 | SM00146 | |
| Domain | Phox | 5.68e-03 | 52 | 130 | 3 | IPR001683 | |
| Domain | p53-like_TF_DNA-bd | 5.99e-03 | 53 | 130 | 3 | IPR008967 | |
| Domain | HMG_box | 5.99e-03 | 53 | 130 | 3 | PF00505 | |
| Domain | EGF_3 | 6.08e-03 | 235 | 130 | 6 | PS50026 | |
| Domain | TF_T-box | 6.11e-03 | 17 | 130 | 2 | IPR001699 | |
| Domain | TBOX | 6.11e-03 | 17 | 130 | 2 | SM00425 | |
| Domain | TF_T-box_CS | 6.11e-03 | 17 | 130 | 2 | IPR018186 | |
| Domain | - | 6.11e-03 | 17 | 130 | 2 | 2.60.40.820 | |
| Domain | TBOX_3 | 6.11e-03 | 17 | 130 | 2 | PS50252 | |
| Domain | T-box | 6.11e-03 | 17 | 130 | 2 | PF00907 | |
| Domain | TBOX_1 | 6.11e-03 | 17 | 130 | 2 | PS01283 | |
| Domain | TBOX_2 | 6.11e-03 | 17 | 130 | 2 | PS01264 | |
| Domain | HMG_BOX_2 | 6.31e-03 | 54 | 130 | 3 | PS50118 | |
| Domain | HMG | 6.31e-03 | 54 | 130 | 3 | SM00398 | |
| Domain | - | 6.64e-03 | 55 | 130 | 3 | 1.10.30.10 | |
| Domain | PI3_PI4_kinase | 6.84e-03 | 18 | 130 | 2 | PF00454 | |
| Domain | PI3_4_KINASE_1 | 6.84e-03 | 18 | 130 | 2 | PS00915 | |
| Domain | PI3_4_KINASE_2 | 6.84e-03 | 18 | 130 | 2 | PS00916 | |
| Domain | PI3/4_kinase_cat_dom | 6.84e-03 | 18 | 130 | 2 | IPR000403 | |
| Domain | PI3_4_KINASE_3 | 6.84e-03 | 18 | 130 | 2 | PS50290 | |
| Pathway | KEGG_MEDICUS_VARIANT_CDH1_REDUCED_EXPRESSION_TO_BETA_CATENIN_SIGNALING_PATHWAY | 2.23e-07 | 8 | 108 | 4 | M47413 | |
| Pathway | REACTOME_RUNX3_REGULATES_WNT_SIGNALING | 8.60e-06 | 6 | 108 | 3 | MM15542 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_SALMONELLA_AVRA_TO_BETA_CATENIN_SIGNALING_PATHWAY | 8.60e-06 | 6 | 108 | 3 | M47736 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_KSHV_LANA_TO_WNT_SIGNALING_PATHWAY | 1.50e-05 | 7 | 108 | 3 | M47465 | |
| Pathway | REACTOME_REGULATION_OF_MITF_M_DEPENDENT_GENES_INVOLVED_IN_CELL_CYCLE_AND_PROLIFERATION | 2.38e-05 | 8 | 108 | 3 | MM17229 | |
| Pathway | REACTOME_BINDING_OF_TCF_LEF_CTNNB1_TO_TARGET_GENE_PROMOTERS | 2.38e-05 | 8 | 108 | 3 | M27359 | |
| Pathway | REACTOME_RUNX3_REGULATES_WNT_SIGNALING | 2.38e-05 | 8 | 108 | 3 | M27821 | |
| Pathway | PID_BETA_CATENIN_NUC_PATHWAY | 3.34e-05 | 80 | 108 | 6 | M223 | |
| Pathway | KEGG_ENDOMETRIAL_CANCER | 4.69e-05 | 52 | 108 | 5 | M19877 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_AXIN_TO_WNT_SIGNALING_PATHWAY | 5.05e-05 | 10 | 108 | 3 | M47486 | |
| Pathway | REACTOME_REPRESSION_OF_WNT_TARGET_GENES | 5.05e-05 | 10 | 108 | 3 | MM15156 | |
| Pathway | KEGG_THYROID_CANCER | 6.68e-05 | 29 | 108 | 4 | M523 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_APC_TO_WNT_SIGNALING_PATHWAY | 9.15e-05 | 12 | 108 | 3 | M47410 | |
| Pathway | REACTOME_CA2_PATHWAY | 1.10e-04 | 62 | 108 | 5 | M27321 | |
| Pathway | WP_ENDOMETRIAL_CANCER | 1.19e-04 | 63 | 108 | 5 | M39623 | |
| Pathway | REACTOME_REPRESSION_OF_WNT_TARGET_GENES | 1.50e-04 | 14 | 108 | 3 | M27402 | |
| Pathway | REACTOME_MITF_M_DEPENDENT_GENE_EXPRESSION | 2.28e-04 | 16 | 108 | 3 | MM17241 | |
| Pathway | REACTOME_REGULATION_OF_MITF_M_DEPENDENT_GENES_INVOLVED_IN_CELL_CYCLE_AND_PROLIFERATION | 2.75e-04 | 17 | 108 | 3 | M48240 | |
| Pathway | WP_AMPLIFICATION_AND_EXPANSION_OF_ONCOGENIC_PATHWAYS_AS_METASTATIC_TRAITS | 2.75e-04 | 17 | 108 | 3 | M39443 | |
| Pathway | KEGG_MEDICUS_VARIANT_LRP6_OVEREXPRESSION_TO_WNT_SIGNALING_PATHWAY | 3.81e-04 | 45 | 108 | 4 | M47412 | |
| Pathway | KEGG_MEDICUS_REFERENCE_WNT_SIGNALING_PATHWAY | 4.15e-04 | 46 | 108 | 4 | M47409 | |
| Pathway | KEGG_CALCIUM_SIGNALING_PATHWAY | 4.34e-04 | 178 | 108 | 7 | M2890 | |
| Pathway | KEGG_PROSTATE_CANCER | 5.99e-04 | 89 | 108 | 5 | M13191 | |
| Pathway | REACTOME_HEPARAN_SULFATE_HEPARIN_HS_GAG_METABOLISM | 7.67e-04 | 54 | 108 | 4 | MM14633 | |
| Pathway | KEGG_BASAL_CELL_CARCINOMA | 8.23e-04 | 55 | 108 | 4 | M17807 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CA2_ENTRY_VOLTAGE_GATED_CA2_CHANNEL | 8.90e-04 | 25 | 108 | 3 | M47948 | |
| Pathway | WP_HIPPO_SIGNALING_REGULATION | 9.28e-04 | 98 | 108 | 5 | M39830 | |
| Pathway | REACTOME_HEPARAN_SULFATE_HEPARIN_HS_GAG_METABOLISM | 9.42e-04 | 57 | 108 | 4 | M692 | |
| Pathway | KEGG_ACUTE_MYELOID_LEUKEMIA | 9.42e-04 | 57 | 108 | 4 | M19888 | |
| Pathway | REACTOME_FORMATION_OF_THE_BETA_CATENIN_TCF_TRANSACTIVATING_COMPLEX | 1.00e-03 | 26 | 108 | 3 | MM14793 | |
| Pathway | KEGG_MELANOGENESIS | 1.06e-03 | 101 | 108 | 5 | M7761 | |
| Pubmed | 1.08e-07 | 12 | 136 | 4 | 32414917 | ||
| Pubmed | TCF transcription factors: molecular switches in carcinogenesis. | 2.33e-07 | 4 | 136 | 3 | 10528152 | |
| Pubmed | Mapping canonical Wnt signaling in the developing and adult retina. | 2.33e-07 | 4 | 136 | 3 | 17065530 | |
| Pubmed | Phosphorylation of TCF proteins by homeodomain-interacting protein kinase 2. | 5.82e-07 | 5 | 136 | 3 | 21285352 | |
| Pubmed | 1.16e-06 | 6 | 136 | 3 | 9488439 | ||
| Pubmed | SLUG: a new target of lymphoid enhancer factor-1 in human osteoblasts. | 1.16e-06 | 6 | 136 | 3 | 20128911 | |
| Pubmed | Thymine DNA glycosylase promotes transactivation of β-catenin/TCFs by cooperating with CBP. | 1.16e-06 | 6 | 136 | 3 | 24748645 | |
| Pubmed | 1.16e-06 | 6 | 136 | 3 | 23152144 | ||
| Pubmed | Dazap2 modulates transcription driven by the Wnt effector TCF-4. | 1.16e-06 | 6 | 136 | 3 | 19304756 | |
| Pubmed | Mitotic internalization of planar cell polarity proteins preserves tissue polarity. | 2.02e-06 | 7 | 136 | 3 | 21743464 | |
| Pubmed | β-catenin and γ-catenin are dispensable for T lymphocytes and AML leukemic stem cells. | 2.02e-06 | 7 | 136 | 3 | 32820720 | |
| Pubmed | RUNX3 attenuates beta-catenin/T cell factors in intestinal tumorigenesis. | 2.02e-06 | 7 | 136 | 3 | 18772112 | |
| Pubmed | 2.02e-06 | 7 | 136 | 3 | 19303461 | ||
| Pubmed | Hyperactive Wnt signaling changes the developmental potential of embryonic lung endoderm. | 2.65e-06 | 25 | 136 | 4 | 15186480 | |
| Pubmed | 3.23e-06 | 8 | 136 | 3 | 33500317 | ||
| Pubmed | 3.66e-06 | 27 | 136 | 4 | 23824573 | ||
| Pubmed | Wnt3a regulates Lef-1 expression during airway submucosal gland morphogenesis. | 4.83e-06 | 9 | 136 | 3 | 17335794 | |
| Pubmed | Central role for PICALM in amyloid-β blood-brain barrier transcytosis and clearance. | 6.88e-06 | 10 | 136 | 3 | 26005850 | |
| Pubmed | A critical role for the Wnt effector Tcf4 in adult intestinal homeostatic self-renewal. | 6.88e-06 | 10 | 136 | 3 | 22393260 | |
| Pubmed | 9.43e-06 | 11 | 136 | 3 | 24639464 | ||
| Pubmed | 9.43e-06 | 11 | 136 | 3 | 37225424 | ||
| Pubmed | Expression of Tcf/Lef and sFrp and localization of beta-catenin in the developing mouse lung. | 9.43e-06 | 11 | 136 | 3 | 11731265 | |
| Pubmed | 9.47e-06 | 34 | 136 | 4 | 32866472 | ||
| Pubmed | 1.07e-05 | 126 | 136 | 6 | 17897319 | ||
| Pubmed | Hippocampus development and generation of dentate gyrus granule cells is regulated by LEF1. | 1.25e-05 | 12 | 136 | 3 | 10631168 | |
| Pubmed | All Tcf HMG box transcription factors interact with Groucho-related co-repressors. | 1.25e-05 | 12 | 136 | 3 | 11266540 | |
| Pubmed | Integrated analysis of Wnt signalling system component gene expression. | 1.34e-05 | 37 | 136 | 4 | 35831952 | |
| Pubmed | 1.34e-05 | 37 | 136 | 4 | 15342465 | ||
| Pubmed | Tissue-specific requirements of beta-catenin in external genitalia development. | 1.49e-05 | 38 | 136 | 4 | 18635608 | |
| Pubmed | SNX18 shares a redundant role with SNX9 and modulates endocytic trafficking at the plasma membrane. | 1.52e-05 | 2 | 136 | 2 | 20427313 | |
| Pubmed | Striking differences of LDL receptor-related protein 1B expression in mouse and human. | 1.52e-05 | 2 | 136 | 2 | 15963947 | |
| Pubmed | 1.52e-05 | 2 | 136 | 2 | 27044748 | ||
| Pubmed | 1.52e-05 | 2 | 136 | 2 | 9524131 | ||
| Pubmed | Differential expression of the HMG box factors TCF-1 and LEF-1 during murine embryogenesis. | 1.52e-05 | 2 | 136 | 2 | 8223271 | |
| Pubmed | Interaction between variants of two glycosyltransferase genes in IgA nephropathy. | 1.52e-05 | 2 | 136 | 2 | 19357720 | |
| Pubmed | 1.52e-05 | 2 | 136 | 2 | 26022336 | ||
| Pubmed | 1.52e-05 | 2 | 136 | 2 | 28660714 | ||
| Pubmed | Microenvironmental regulation of epithelial-mesenchymal transitions in cancer. | 1.52e-05 | 2 | 136 | 2 | 23002209 | |
| Pubmed | Differential LEF1 and TCF4 expression is involved in melanoma cell phenotype switching. | 1.52e-05 | 2 | 136 | 2 | 21599871 | |
| Pubmed | 1.52e-05 | 2 | 136 | 2 | 19536785 | ||
| Pubmed | 1.52e-05 | 2 | 136 | 2 | 22475533 | ||
| Pubmed | 1.52e-05 | 2 | 136 | 2 | 9462507 | ||
| Pubmed | 1.52e-05 | 2 | 136 | 2 | 15703190 | ||
| Pubmed | A role for Rab11 in the homeostasis of the endosome-lysosomal pathway. | 1.52e-05 | 2 | 136 | 2 | 30981667 | |
| Pubmed | 1.52e-05 | 2 | 136 | 2 | 37310356 | ||
| Pubmed | 1.52e-05 | 2 | 136 | 2 | 38169425 | ||
| Pubmed | Cytokines alter IgA1 O-glycosylation by dysregulating C1GalT1 and ST6GalNAc-II enzymes. | 1.52e-05 | 2 | 136 | 2 | 24398680 | |
| Pubmed | 1.52e-05 | 2 | 136 | 2 | 22111711 | ||
| Pubmed | 1.52e-05 | 2 | 136 | 2 | 29305962 | ||
| Pubmed | Cell-autonomous requirement for TCF1 and LEF1 in the development of Natural Killer T cells. | 1.52e-05 | 2 | 136 | 2 | 26490636 | |
| Pubmed | 1.52e-05 | 2 | 136 | 2 | 9153229 | ||
| Pubmed | 1.52e-05 | 2 | 136 | 2 | 34445520 | ||
| Pubmed | 1.52e-05 | 2 | 136 | 2 | 16424171 | ||
| Pubmed | 1.52e-05 | 2 | 136 | 2 | 12019334 | ||
| Pubmed | 1.52e-05 | 2 | 136 | 2 | 36044864 | ||
| Pubmed | 1.52e-05 | 2 | 136 | 2 | 28170089 | ||
| Pubmed | 1.52e-05 | 2 | 136 | 2 | 1783375 | ||
| Pubmed | A novel role for 3-O-sulfated heparan sulfate in herpes simplex virus 1 entry. | 1.52e-05 | 2 | 136 | 2 | 10520990 | |
| Pubmed | 1.52e-05 | 2 | 136 | 2 | 30918012 | ||
| Pubmed | 1.52e-05 | 2 | 136 | 2 | 37741305 | ||
| Pubmed | 1.52e-05 | 2 | 136 | 2 | 15304505 | ||
| Pubmed | 1.52e-05 | 2 | 136 | 2 | 22493503 | ||
| Pubmed | 1.52e-05 | 2 | 136 | 2 | 15790735 | ||
| Pubmed | Rab11 regulates E-cadherin expression and induces cell transformation in colorectal carcinoma. | 1.52e-05 | 2 | 136 | 2 | 25117932 | |
| Pubmed | 1.52e-05 | 2 | 136 | 2 | 20547676 | ||
| Pubmed | 1.52e-05 | 2 | 136 | 2 | 24585383 | ||
| Pubmed | Rab11b regulates the trafficking and recycling of the epithelial sodium channel (ENaC). | 1.52e-05 | 2 | 136 | 2 | 22129970 | |
| Pubmed | RAB11A and RAB11B control mitotic spindle function in intestinal epithelial progenitor cells. | 1.52e-05 | 2 | 136 | 2 | 37424454 | |
| Pubmed | FOXM1 and CHD4 expression is associated with chemoresistance in hepatoblastoma. | 1.52e-05 | 2 | 136 | 2 | 38761648 | |
| Pubmed | 1.52e-05 | 2 | 136 | 2 | 34615872 | ||
| Pubmed | 1.52e-05 | 2 | 136 | 2 | 23224985 | ||
| Pubmed | 1.52e-05 | 2 | 136 | 2 | 19269971 | ||
| Pubmed | 1.65e-05 | 39 | 136 | 4 | 35781329 | ||
| Pubmed | 1.71e-05 | 81 | 136 | 5 | 39217171 | ||
| Pubmed | Large-scale analysis of ion channel gene expression in the mouse heart during perinatal development. | 1.88e-05 | 139 | 136 | 6 | 16985003 | |
| Pubmed | Role of CD34 family members in lumen formation in the developing kidney. | 2.06e-05 | 14 | 136 | 3 | 27542690 | |
| Pubmed | 2.06e-05 | 14 | 136 | 3 | 15226261 | ||
| Pubmed | 2.06e-05 | 14 | 136 | 3 | 17360773 | ||
| Pubmed | 2.06e-05 | 14 | 136 | 3 | 15082773 | ||
| Pubmed | Wnt3a-/--like phenotype and limb deficiency in Lef1(-/-)Tcf1(-/-) mice. | 2.06e-05 | 14 | 136 | 3 | 10090727 | |
| Pubmed | 2.06e-05 | 14 | 136 | 3 | 33195246 | ||
| Pubmed | Phases of canonical Wnt signaling during the development of mouse intestinal epithelium. | 2.57e-05 | 15 | 136 | 3 | 17681174 | |
| Pubmed | β-Catenin-SOX2 signaling regulates the fate of developing airway epithelium. | 2.57e-05 | 15 | 136 | 3 | 22421361 | |
| Pubmed | Canonical Wnt signaling in differentiated osteoblasts controls osteoclast differentiation. | 2.57e-05 | 15 | 136 | 3 | 15866165 | |
| Pubmed | ADAMTS2 promotes radial migration by activating TGF-β signaling in the developing neocortex. | 2.57e-05 | 15 | 136 | 3 | 38871984 | |
| Pubmed | Hindgut defects and transformation of the gastro-intestinal tract in Tcf4(-/-)/Tcf1(-/-) embryos. | 3.16e-05 | 16 | 136 | 3 | 15057272 | |
| Pubmed | 3.16e-05 | 16 | 136 | 3 | 9988767 | ||
| Pubmed | Hedgehog regulation of epithelial cell state and morphogenesis in the larynx. | 3.82e-05 | 17 | 136 | 3 | 36398878 | |
| Pubmed | OXR1 USP25 CHD4 NCAPH2 ZFC3H1 LMO4 LRP1B MPRIP CRNKL1 DST LMO2 SULF1 ARIH2 LRP1 LRP2 USPL1 | 4.47e-05 | 1285 | 136 | 16 | 35914814 | |
| Pubmed | 4.48e-05 | 50 | 136 | 4 | 27510977 | ||
| Pubmed | 4.54e-05 | 3 | 136 | 2 | 9839716 | ||
| Pubmed | 4.54e-05 | 3 | 136 | 2 | 23640058 | ||
| Pubmed | 4.54e-05 | 3 | 136 | 2 | 18247340 | ||
| Pubmed | Contactin-1 reduces E-cadherin expression via activating AKT in lung cancer. | 4.54e-05 | 3 | 136 | 2 | 23724143 | |
| Pubmed | 4.54e-05 | 3 | 136 | 2 | 17043652 | ||
| Pubmed | Differential expression of LEF1/TCFs family members in colonic carcinogenesis. | 4.54e-05 | 3 | 136 | 2 | 27433921 | |
| Pubmed | 4.54e-05 | 3 | 136 | 2 | 22875805 | ||
| Pubmed | Structural basis for the recognition of ldb1 by the N-terminal LIM domains of LMO2 and LMO4. | 4.54e-05 | 3 | 136 | 2 | 12727888 | |
| Pubmed | 4.54e-05 | 3 | 136 | 2 | 21752154 | ||
| Pubmed | 4.54e-05 | 3 | 136 | 2 | 25533808 | ||
| GeneFamily | Low density lipoprotein receptors | 3.75e-05 | 13 | 94 | 3 | 634 | |
| GeneFamily | Sulfotransferases, membrane bound | 3.97e-05 | 37 | 94 | 4 | 763 | |
| GeneFamily | Calcium voltage-gated channel subunits | 3.24e-04 | 26 | 94 | 3 | 253 | |
| GeneFamily | Sorting nexins|PX-BAR domain containing | 1.71e-03 | 12 | 94 | 2 | 1290 | |
| ToppCell | severe_COVID-19-CD8+_T_naive|World / disease group, cell group and cell class (v2) | 4.63e-07 | 153 | 136 | 7 | 422483445af49c277fc8962d76a46ffafd872422 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-OPC-OPC-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.06e-07 | 155 | 136 | 7 | 77fdae85d36efb776db977eb424b32487ef222e4 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Macroglial-oligodendrocyte_precursor_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.84e-06 | 188 | 136 | 7 | a244fcd092d5bd544e503366b1439b0fbc1ee00e | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Macroglial-Oligodendrocyte_progenitor_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.84e-06 | 188 | 136 | 7 | c8530c9ff98666c64a94683261af4288cb790a7e | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-OPC-OPC-G|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.98e-06 | 190 | 136 | 7 | 6c7e1086c0a274cd5527c3104106e372811c9905 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-OPC-OPC|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.43e-06 | 196 | 136 | 7 | f374cb3ec31c6eef2cef9e07547bfd1e380553af | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-OPC|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.43e-06 | 196 | 136 | 7 | 671c380b58d7f634b4fbec38c357d357ea4f3535 | |
| ToppCell | VE-mono1-|VE / Condition, Cell_class and T cell subcluster | 2.60e-06 | 198 | 136 | 7 | 2959d6e4992c36040ec9637f5a2daed02b35cf30 | |
| ToppCell | VE-mono1|VE / Condition, Cell_class and T cell subcluster | 2.60e-06 | 198 | 136 | 7 | c742871b8ec4720b1848991551c7c1f4000ebd85 | |
| ToppCell | PBMC-Mild-Myeloid-Classical_Monocyte-Classical_Monocyte-cMono_4|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.60e-06 | 198 | 136 | 7 | 06201b34d3e38f22c93b759511f7b376504bac06 | |
| ToppCell | PBMC-Mild-Myeloid-Classical_Monocyte-Classical_Monocyte-cMono_4|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.60e-06 | 198 | 136 | 7 | 1ca91559fef231896e16180f5e050155c38f7cfa | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.69e-06 | 199 | 136 | 7 | 333056c2abe9724efeab542c0365fcfe4eff8f18 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC-OPC|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.69e-06 | 199 | 136 | 7 | e60ecbb8fa7bcd3e2ce7d78f6efb2cfd1fd77698 | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_airway-airway_epithelial-Ciliated|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 2.78e-06 | 200 | 136 | 7 | 96701a4d57753f5ec0dd5c7550054bbcc946bc5f | |
| ToppCell | Caecum-(4)_Monocyte-(40)_Monocyte|Caecum / shred on region, Cell_type, and subtype | 2.78e-06 | 200 | 136 | 7 | b078058efc51f0ff4d92123b712933b32824c655 | |
| ToppCell | Caecum-(4)_Monocyte|Caecum / shred on region, Cell_type, and subtype | 2.78e-06 | 200 | 136 | 7 | 6bfd6ab395e09087aeedc9a7c9ada1b4b8a26194 | |
| ToppCell | Caecum-Monocyte|Caecum / Region, Cell class and subclass | 2.78e-06 | 200 | 136 | 7 | 9e8d38d024a315512521b349e8ac7caa56219daf | |
| ToppCell | Caecum-Monocyte-Monocyte|Caecum / Region, Cell class and subclass | 2.78e-06 | 200 | 136 | 7 | d33619b6c721eae3ebe50fba6b9d31fa99f2248f | |
| ToppCell | severe-CD163+_Monocytes_(Sample_ID1_d7)|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.78e-06 | 200 | 136 | 7 | 4943fe826d5fcc3dfeb8b99a7415848f3fecc994 | |
| ToppCell | Substantia_nigra-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Otx2-Inhibitory_Neuron.Gad1Gad2.Otx2-Chrna3_(SN/VTA_(dorsal_SNr))-|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 3.41e-06 | 75 | 136 | 5 | 730a08f846a155d2c892259f2c610081d40fc2c8 | |
| ToppCell | Substantia_nigra-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Otx2|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 3.41e-06 | 75 | 136 | 5 | f0185de0ce497997df1027a51c099d91294bba07 | |
| ToppCell | Substantia_nigra-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Otx2-Inhibitory_Neuron.Gad1Gad2.Otx2-Chrna3_(SN/VTA_(dorsal_SNr))|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 3.41e-06 | 75 | 136 | 5 | 59fe56388697037b335f334cb3461f15c7b3b506 | |
| ToppCell | PND03-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT2-AT2_prolif|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.30e-05 | 168 | 136 | 6 | 08f6e171a1ea5cf65149744296d0fcd6c7b9684e | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.39e-05 | 170 | 136 | 6 | 5570c0e825bca77613bf0ebde620cf744fa1cb84 | |
| ToppCell | droplet-Lung-1m-Hematologic-myeloid|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.87e-05 | 179 | 136 | 6 | 6d2458a887047b5c20389f08345ff5aac7c683e6 | |
| ToppCell | facs-Lung-18m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l25|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.93e-05 | 180 | 136 | 6 | 67c5068b660cd5e727a665cefe3bd5f8ae887221 | |
| ToppCell | metastatic_Brain-Myeloid_cells-Pleural_Mac|metastatic_Brain / Location, Cell class and cell subclass | 1.93e-05 | 180 | 136 | 6 | 7de1c8ab1152fa517c6b4830d93ff53a19fca3d7 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.99e-05 | 181 | 136 | 6 | 6956ecd6264f7469a25e555673bce4eb97d28f7a | |
| ToppCell | facs-Kidney-nan-3m|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.05e-05 | 182 | 136 | 6 | 4c5d14e33ebdf117b5aa9e2f57aaa89aa51f72bf | |
| ToppCell | CV-Healthy-7|CV / Virus stimulation, Condition and Cluster | 2.18e-05 | 184 | 136 | 6 | 0e5cc77aaa73ceb791f8be7456177577fd2e5586 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex_-18m-Macroglial-Oligodendrocyte_progenitor_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.18e-05 | 184 | 136 | 6 | 278a7ed764c326450cb70e69ed2175980eaf5fe0 | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-alveolar_macrophage|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.18e-05 | 184 | 136 | 6 | 8fa30789c9d583188667cf375d2218e392dd40bc | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex_-18m-Macroglial-oligodendrocyte_precursor_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.18e-05 | 184 | 136 | 6 | 8d86e125257ff1d3af8d90577a8b3f0321eca21c | |
| ToppCell | CV-Healthy-7|Healthy / Virus stimulation, Condition and Cluster | 2.25e-05 | 185 | 136 | 6 | 1979d189c204f4c2893e3170a514ee7d5523406c | |
| ToppCell | droplet-Lung-nan-21m-Myeloid-Alveolar_Macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.32e-05 | 186 | 136 | 6 | f1aa0c58336d23bcbe52a59e7af954d20085bdb6 | |
| ToppCell | Myeloid-B_(Activated_Macrophage)|World / shred on cell class and cell subclass (v4) | 2.32e-05 | 186 | 136 | 6 | 33d731a7883d75e4e7db83b641cdb1e9a39938bf | |
| ToppCell | droplet-Lung-nan-21m-Myeloid-alveolar_macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.32e-05 | 186 | 136 | 6 | 8f77e552e613b6e124443c7f6ef5c1316a5ff8db | |
| ToppCell | droplet-Marrow-nan-21m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.39e-05 | 187 | 136 | 6 | 20b25b0d08550a1e8e997c5ce67d8e34bf7fc398 | |
| ToppCell | droplet-Lung-30m-Hematologic-myeloid-alveolar_macrophage-alveolar_macrophage|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.54e-05 | 189 | 136 | 6 | 98f517af255ef234eefc3ed7e6c1d63331ab8af0 | |
| ToppCell | droplet-Lung-30m-Hematologic-myeloid-alveolar_macrophage|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.54e-05 | 189 | 136 | 6 | f7e9b6e6a4de297b660a5b6c9a62f860c147185e | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.54e-05 | 189 | 136 | 6 | e32172ad09e93f6ac6ea2b92145b2b73003f7970 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Macroglial-oligodendrocyte_precursor_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.61e-05 | 190 | 136 | 6 | 9b825b2586c7b173ff27fcf2abc5860faf50984a | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Macroglial-Oligodendrocyte_progenitor_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.61e-05 | 190 | 136 | 6 | d146af1926474328a7c822bc140c4dda66e1bbfb | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-3m-Macroglial-oligodendrocyte_precursor_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.69e-05 | 191 | 136 | 6 | ece87127f85939e61b1048d968ed96f0e87c3a79 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-3m-Macroglial-Oligodendrocyte_progenitor_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.69e-05 | 191 | 136 | 6 | 478e8341ee03b05501e2233e02cef5f97492c95d | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_alveolar-distal|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 2.77e-05 | 192 | 136 | 6 | b7c01e12b3e9be960a741b08835f1dfff65d0d47 | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia/MHC-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.94e-05 | 194 | 136 | 6 | 08fad7591c20568de797cf8e206de2d0b1d78aab | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Immune-Myeloid-Monocytic-Non-classical_Monocyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.02e-05 | 195 | 136 | 6 | 1d58585557bf8e9ce4d514e128d3a902b526331d | |
| ToppCell | COVID-19_Mild-PLT_5|COVID-19_Mild / Disease Group and Platelet Clusters | 3.02e-05 | 195 | 136 | 6 | bdf9a6ea1bd83c72a834c45f86ce3f4643a9bef3 | |
| ToppCell | mild_COVID-19_(asymptomatic)-Non-classical_Monocyte|World / disease group, cell group and cell class (v2) | 3.02e-05 | 195 | 136 | 6 | eb809331557f8c40de45b1208cbc49b621930a4b | |
| ToppCell | Adult-Immune-alveolar_macrophage_(MARCO_positive)|Adult / Lineage, Cell type, age group and donor | 3.02e-05 | 195 | 136 | 6 | 55e25f702af19146a161861cfd15f40bbda1dc35 | |
| ToppCell | VE-granulo1-|VE / Condition, Cell_class and T cell subcluster | 3.11e-05 | 196 | 136 | 6 | ab3f2ce294c7e503d86254a195be0cf500a2c5e4 | |
| ToppCell | COVID-19_Moderate-Non-classical_Monocyte|COVID-19_Moderate / disease group, cell group and cell class | 3.11e-05 | 196 | 136 | 6 | 256c557fa11414c9d2cbb1fcff33f482ee1c78ac | |
| ToppCell | VE-granulo1|VE / Condition, Cell_class and T cell subcluster | 3.11e-05 | 196 | 136 | 6 | 6dbd3acb30173d7f0b7bca0a82f435f00ca85835 | |
| ToppCell | 10x5'-lymph-node_spleen-Myeloid_Monocytic-Nonclassical_monocytes|lymph-node_spleen / Manually curated celltypes from each tissue | 3.20e-05 | 197 | 136 | 6 | 67f19dd30adb03300f04219d0295bc1c1788f626 | |
| ToppCell | COVID-19_Moderate-Classical_Monocyte|COVID-19_Moderate / disease group, cell group and cell class | 3.20e-05 | 197 | 136 | 6 | 98d4107e457e7399a84439acd73bf8f59598971b | |
| ToppCell | PBMC-Mild-Myeloid-Classical_Monocyte-Classical_Monocyte|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.29e-05 | 198 | 136 | 6 | d347462ba6cb1c5a59c86dffbbe914cbc1e9cf16 | |
| ToppCell | PBMC-Mild-Myeloid-Classical_Monocyte-Classical_Monocyte|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.29e-05 | 198 | 136 | 6 | c5a22846bccff948f90bc1d5fe309907dcd08348 | |
| ToppCell | COVID-19_Mild-Myeloid-Classical_Monocyte|COVID-19_Mild / Disease group, lineage and cell class | 3.29e-05 | 198 | 136 | 6 | e78d027a095473af555762a4d542a73f5bb2e166 | |
| ToppCell | Monocytes-Phagocytic_CD16+_macrophages|World / Immune cells in Kidney/Urine in Lupus Nephritis | 3.29e-05 | 198 | 136 | 6 | 09009cc966bf1503c3b15dfa079a6c5f6ad1f507 | |
| ToppCell | PBMC-Mild-Myeloid-Classical_Monocyte|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.29e-05 | 198 | 136 | 6 | c49c71b34151d82b8795763bcb633c301c35f659 | |
| ToppCell | PBMC-Mild-Myeloid-Classical_Monocyte|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.29e-05 | 198 | 136 | 6 | 4780f0276546962a2fc9f1041cfe49d2919d72b2 | |
| ToppCell | severe_COVID-19-Classical_Monocyte|severe_COVID-19 / disease group, cell group and cell class (v2) | 3.29e-05 | 198 | 136 | 6 | 40dd3333945aa0c9120296b75155c621f462dbe8 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Myeloid-Monocytic|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.29e-05 | 198 | 136 | 6 | b19a089eb80af3428891f2ff00e53a6e11894fa3 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Myeloid-Monocytic-Classical_Monocyte-Mono_c2-CD14-HLA-DPB1|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.39e-05 | 199 | 136 | 6 | 4fc03377c017209111561789226621d258291481 | |
| ToppCell | Sigmoid-(1)_T_cell-(14)_Tcm|Sigmoid / shred on region, Cell_type, and subtype | 3.39e-05 | 199 | 136 | 6 | ec454fa22fb7f50a947bdf4c4bb6f0ba13f62b4c | |
| ToppCell | Fibroblasts|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 3.39e-05 | 199 | 136 | 6 | 40de6d4a31cf22efa2864f79e4ec8e2b7bfc9d4a | |
| ToppCell | VE-granulo2|VE / Condition, Cell_class and T cell subcluster | 3.39e-05 | 199 | 136 | 6 | 05b47fdc01eccee0eaf4c781eeff93c47fe0533e | |
| ToppCell | healthy_donor-Myeloid|healthy_donor / Disease condition, Lineage, Cell class and subclass | 3.39e-05 | 199 | 136 | 6 | d41994e08f7c3f5bd865b689db8f032efbe88d24 | |
| ToppCell | healthy_donor-Myeloid-Monocytic|healthy_donor / Disease condition, Lineage, Cell class and subclass | 3.39e-05 | 199 | 136 | 6 | bd66a8d1a7cc92313328acc7c7ae0442faff951e | |
| ToppCell | control-HLA-DR+_CD83+_Monocyte|control / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.39e-05 | 199 | 136 | 6 | f1b370d2869ad29c9d8ff41fdcc486fffa781ee2 | |
| ToppCell | Fibroblasts-CD34+_Fibroblasts|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 3.39e-05 | 199 | 136 | 6 | 13ff7409e200a0b46cdb7924d15ef33639693622 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC-OPC-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.39e-05 | 199 | 136 | 6 | 19a97e27a4758e794ce7246d295e112b47931a48 | |
| ToppCell | Sigmoid-T_cell-Tcm|Sigmoid / Region, Cell class and subclass | 3.39e-05 | 199 | 136 | 6 | f7c729eaa3c8fd5a05cb6f79cac9b8f199c8092b | |
| ToppCell | VE-granulo2-|VE / Condition, Cell_class and T cell subcluster | 3.39e-05 | 199 | 136 | 6 | 455e92047201ddd0c29a437a838e5fa135de7995 | |
| ToppCell | mild_COVID-19_(asymptomatic)-Classical_Monocyte|mild_COVID-19_(asymptomatic) / disease group, cell group and cell class (v2) | 3.39e-05 | 199 | 136 | 6 | 73a98d19871ffbc3c631de330998d42e9afa6da2 | |
| ToppCell | Parenchymal-NucSeq-Immune_Myeloid-Monocytic-Monocyte_CD16|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.39e-05 | 199 | 136 | 6 | ac866ae110967c5867ff4601939b79861d43df54 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.0.3.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.39e-05 | 199 | 136 | 6 | 8e9862907b15809d083216e7d6a0f435015e5d15 | |
| ToppCell | mild-cDC|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.48e-05 | 200 | 136 | 6 | 86f585bf9066b179bbcbc703bf43f15da4a07284 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW08-Neuronal-Intermediate|GW08 / Sample Type, Dataset, Time_group, and Cell type. | 3.48e-05 | 200 | 136 | 6 | 401d50fa394fa863fa7836344110ae5c7af3250a | |
| ToppCell | COVID_vent-Myeloid|COVID_vent / Disease condition, Lineage, Cell class and subclass | 3.48e-05 | 200 | 136 | 6 | 621af09aae34226902c03edf556562f3ab35a7d8 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Myeloid-Monocytic-Classical_Monocyte-Mono_c2-CD14-HLA-DPB1|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.48e-05 | 200 | 136 | 6 | 94679f6914dab1551ce1c58542a65c339254451d | |
| ToppCell | mild-HLA-DR+_CD83+_Monocyte|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.48e-05 | 200 | 136 | 6 | 934c2efc780318c66d667ca75be0de350361d351 | |
| ToppCell | Bronchial-10x5prime-Immune_Myeloid|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.48e-05 | 200 | 136 | 6 | d97e9253df98cf6ad3ef4fb28e344ec108d02b1e | |
| ToppCell | COVID-19-COVID-19_Mild-Myeloid-CD14+_Monocyte|COVID-19_Mild / Disease, condition lineage and cell class | 3.48e-05 | 200 | 136 | 6 | f76d3647f8ab5f7be018b0697c911597198e03f5 | |
| ToppCell | Influenza-Influenza_Severe-Myeloid|Influenza_Severe / Disease, condition lineage and cell class | 3.48e-05 | 200 | 136 | 6 | 2bf931ec2c6165698ba600b151fd30d8dd921d95 | |
| ToppCell | COVID_vent-Myeloid-Monocytic-CD14+_Monocyte|COVID_vent / Disease condition, Lineage, Cell class and subclass | 3.48e-05 | 200 | 136 | 6 | e57452b73abb21cb3f645d45523ab93f6bef0243 | |
| ToppCell | LPS_IL1RA-Epithelial_airway-airway_epithelial-Ciliated|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 3.48e-05 | 200 | 136 | 6 | 4992dbf0514d674017315dbd20d91dfec0c608e9 | |
| ToppCell | COVID_vent-Myeloid-Monocytic|COVID_vent / Disease condition, Lineage, Cell class and subclass | 3.48e-05 | 200 | 136 | 6 | b0a5bee87700ce38f26f95a6f491da7e27cade51 | |
| ToppCell | Severe-Myeloid-Macrophages-FCN1_high|Severe / Condition, Lineage, Cell class and cell subclass | 3.48e-05 | 200 | 136 | 6 | 449623d6786e30d493f68156b3f1ee8caf9265a6 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC-OPC-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.48e-05 | 200 | 136 | 6 | ad777683adeb2ce45ade570386235e311fa7ea2d | |
| ToppCell | mild-Classical_Monocyte|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.48e-05 | 200 | 136 | 6 | c8b80d4e7f70c66cbbdd0665821bcd5db69c7d35 | |
| ToppCell | mild-CD163+_Monocytes_(Sample_ID1_d7)|mild / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.48e-05 | 200 | 136 | 6 | 99eb02f974ddc8d1882f4a5b34d4503d6ec0a5f5 | |
| ToppCell | Tracheal-10x3prime_v2-Immune_Myeloid-Monocytic|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 3.48e-05 | 200 | 136 | 6 | 4077a85ceb8bb423c06179e16fd870ab95f8a2e8 | |
| ToppCell | COVID-19_Mild-Neu_1|World / 5 Neutrophil clusters in COVID-19 patients | 4.11e-05 | 125 | 136 | 5 | e58c208b4355252ceabe04a468dd19a1f436182c | |
| ToppCell | severe_COVID-19-Treg|World / disease group, cell group and cell class (v2) | 7.54e-05 | 142 | 136 | 5 | cccc2e738eeca342cd937c4cd863571951b2257e | |
| ToppCell | IIH-CD8-proli_CD4|IIH / Condition, Cell_class and T cell subcluster | 8.59e-05 | 146 | 136 | 5 | 7fa6e35def3f7cffbee1e1c2f10b523bab678e14 | |
| ToppCell | droplet-Fat-Scat-21m-Myeloid-nan|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.01e-04 | 151 | 136 | 5 | 79827a76c675dcb82f59c0a45d0f962b02d5bfd6 | |
| ToppCell | LPS-IL1RA-Epithelial_airway-Ciliated_cells|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.01e-04 | 151 | 136 | 5 | 81cf939ed4df9574fbfff265e109cb9f947d7e6e | |
| ToppCell | LPS-IL1RA-Epithelial_airway-Ciliated_cells-Ciliated|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.01e-04 | 151 | 136 | 5 | 9cbcbbc22965a9f0be8364e733d205dd64f2a533 | |
| Drug | baclofen | 1.90e-06 | 191 | 133 | 9 | CID000002284 | |
| Drug | Phthalylsulfathiazole [85-73-4]; Up 200; 10uM; HL60; HT_HG-U133A | 2.55e-06 | 198 | 133 | 9 | 3033_UP | |
| Drug | lavendustin A | 7.59e-06 | 171 | 133 | 8 | CID000003894 | |
| Drug | Clotrimazole [23593-75-1]; Down 200; 11.6uM; MCF7; HT_HG-U133A | 1.76e-05 | 192 | 133 | 8 | 6207_DN | |
| Drug | Tiapride hydrochloride [51012-33-0]; Up 200; 11uM; HL60; HT_HG-U133A | 2.04e-05 | 196 | 133 | 8 | 2331_UP | |
| Drug | Estriol [50-27-1]; Up 200; 13.8uM; PC3; HT_HG-U133A | 2.12e-05 | 197 | 133 | 8 | 5866_UP | |
| Drug | Sulfamethoxypyridazine [80-35-3]; Up 200; 14.2uM; HL60; HT_HG-U133A | 2.20e-05 | 198 | 133 | 8 | 2550_UP | |
| Drug | Ampicillin trihydrate [7177-48-2]; Up 200; 10uM; PC3; HT_HG-U133A | 2.28e-05 | 199 | 133 | 8 | 6307_UP | |
| Drug | 0317956-0000 [391210-11-0]; Up 200; 10uM; PC3; HT_HG-U133A | 2.28e-05 | 199 | 133 | 8 | 3774_UP | |
| Drug | trifluoperazine dihydrochloride; Down 200; 10uM; HL60; HT_HG-U133A | 2.36e-05 | 200 | 133 | 8 | 1165_DN | |
| Disease | chromosome 22q11.2 deletion syndrome, distal (implicated_via_orthology) | 3.00e-05 | 14 | 131 | 3 | DOID:0060413 (implicated_via_orthology) | |
| Disease | Keratosis pilaris decalvans | 5.85e-05 | 3 | 131 | 2 | C0343057 | |
| Disease | epilepsy (implicated_via_orthology) | 9.16e-05 | 163 | 131 | 6 | DOID:1826 (implicated_via_orthology) | |
| Disease | Condition, Preneoplastic | 1.35e-04 | 110 | 131 | 5 | C0282313 | |
| Disease | Precancerous Conditions | 1.35e-04 | 110 | 131 | 5 | C0032927 | |
| Disease | Global developmental delay | 3.26e-04 | 133 | 131 | 5 | C0557874 | |
| Disease | ovarian neoplasm | 3.37e-04 | 134 | 131 | 5 | C0919267 | |
| Disease | Malignant neoplasm of ovary | 3.74e-04 | 137 | 131 | 5 | C1140680 | |
| Disease | Helicobacter Infections | 4.05e-04 | 7 | 131 | 2 | C0079487 | |
| Disease | galactoside 3(4)-L-fucosyltransferase measurement | 4.05e-04 | 7 | 131 | 2 | EFO_0021853 | |
| Disease | Spinocerebellar Ataxia Type 2 | 4.63e-04 | 34 | 131 | 3 | C0752121 | |
| Disease | Spinocerebellar Ataxia Type 1 | 4.63e-04 | 34 | 131 | 3 | C0752120 | |
| Disease | Spinocerebellar Ataxia Type 5 | 4.63e-04 | 34 | 131 | 3 | C0752123 | |
| Disease | Spinocerebellar Ataxia Type 7 | 4.63e-04 | 34 | 131 | 3 | C0752125 | |
| Disease | Spinocerebellar Ataxia Type 6 (disorder) | 4.63e-04 | 34 | 131 | 3 | C0752124 | |
| Disease | Ataxia, Spinocerebellar | 4.63e-04 | 34 | 131 | 3 | C0087012 | |
| Disease | Spinocerebellar Ataxia Type 4 | 5.04e-04 | 35 | 131 | 3 | C0752122 | |
| Disease | N-acetylcarnosine measurement | 5.38e-04 | 8 | 131 | 2 | EFO_0022101 | |
| Disease | Schizophrenia | GABRR1 TCF7L2 CHD4 GRM5 KCNH6 HSPA12A MTOR PTPRZ1 TLR3 LRP1 LRP2 TBX1 | 5.86e-04 | 883 | 131 | 12 | C0036341 |
| Disease | reticulocyte count | EEF1AKMT4-ECE2 RAB11B TCF7L2 OXR1 RAB11A LCP1 ADCY3 PLEK2 EGF IFRD2 CHST12 DEPDC5 CDH1 | 7.87e-04 | 1045 | 131 | 13 | EFO_0007986 |
| Disease | Mesothelioma | 8.06e-04 | 41 | 131 | 3 | C0025500 | |
| Disease | Intellectual Disability | 8.90e-04 | 447 | 131 | 8 | C3714756 | |
| Disease | Congenital Nonbullous Ichthyosiform Erythroderma | 1.05e-03 | 11 | 131 | 2 | C0079154 | |
| Disease | Congenital ichthyosis of skin | 1.05e-03 | 11 | 131 | 2 | cv:C0020758 | |
| Disease | Colorectal Carcinoma | 1.19e-03 | 702 | 131 | 10 | C0009402 | |
| Disease | lung adenocarcinoma (is_implicated_in) | 1.36e-03 | 49 | 131 | 3 | DOID:3910 (is_implicated_in) | |
| Disease | gallbladder cancer (is_implicated_in) | 1.48e-03 | 13 | 131 | 2 | DOID:3121 (is_implicated_in) | |
| Disease | Metabolic Bone Disorder | 1.72e-03 | 14 | 131 | 2 | C0005944 | |
| Disease | thyroid gland papillary carcinoma (is_marker_for) | 1.72e-03 | 14 | 131 | 2 | DOID:3969 (is_marker_for) | |
| Disease | Carcinoma, Granular Cell | 1.81e-03 | 116 | 131 | 4 | C0205644 | |
| Disease | Adenocarcinoma, Tubular | 1.81e-03 | 116 | 131 | 4 | C0205645 | |
| Disease | Adenocarcinoma, Oxyphilic | 1.81e-03 | 116 | 131 | 4 | C0205642 | |
| Disease | Carcinoma, Cribriform | 1.81e-03 | 116 | 131 | 4 | C0205643 | |
| Disease | Adenocarcinoma, Basal Cell | 1.81e-03 | 116 | 131 | 4 | C0205641 | |
| Disease | Adenocarcinoma | 1.81e-03 | 116 | 131 | 4 | C0001418 | |
| Disease | Osteopenia | 1.98e-03 | 15 | 131 | 2 | C0029453 | |
| Disease | urate measurement, spine bone mineral density | 2.21e-03 | 58 | 131 | 3 | EFO_0004531, EFO_0007701 | |
| Disease | body mass index, type 2 diabetes mellitus | 2.25e-03 | 16 | 131 | 2 | EFO_0004340, MONDO_0005148 | |
| Disease | Mammary Carcinoma, Human | 2.44e-03 | 525 | 131 | 8 | C4704874 | |
| Disease | Mammary Neoplasms, Human | 2.44e-03 | 525 | 131 | 8 | C1257931 | |
| Disease | Mammary Neoplasms | 2.50e-03 | 527 | 131 | 8 | C1458155 | |
| Disease | visfatin measurement | 2.55e-03 | 17 | 131 | 2 | EFO_0801230 | |
| Disease | serum dimethylarginine measurement | 2.80e-03 | 63 | 131 | 3 | EFO_0005418 | |
| Disease | Polyarthritis, Juvenile, Rheumatoid Factor Positive | 2.81e-03 | 131 | 131 | 4 | C4704862 | |
| Disease | Polyarthritis, Juvenile, Rheumatoid Factor Negative | 2.81e-03 | 131 | 131 | 4 | C4552091 | |
| Disease | Juvenile arthritis | 2.81e-03 | 131 | 131 | 4 | C3495559 | |
| Disease | Juvenile psoriatic arthritis | 2.81e-03 | 131 | 131 | 4 | C3714758 | |
| Disease | Breast Carcinoma | 2.84e-03 | 538 | 131 | 8 | C0678222 | |
| Disease | fish consumption measurement | 2.92e-03 | 64 | 131 | 3 | EFO_0010139 | |
| Disease | Juvenile-Onset Still Disease | 3.14e-03 | 135 | 131 | 4 | C0087031 | |
| Disease | aggressive behaviour measurement, ADHD symptom measurement | 3.47e-03 | 68 | 131 | 3 | EFO_0007826, EFO_0007860 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| RDREWKKYEFHYDNV | 1431 | O00555 | |
| QSLLFHFLDEWLYKF | 86 | Q8IWT0 | |
| HWEKYNNRYTESRSF | 106 | Q14507 | |
| DVFLLRTQAEHYLWY | 541 | O75366 | |
| KVANYFDWISYHVGR | 561 | P05156 | |
| YAKARLWFHSNFLYI | 171 | P19397 | |
| FSFWKYHYDRQAEII | 181 | Q86XM0 | |
| YKYFAHRRTWDAAER | 3181 | P13611 | |
| WYKFDENYAFLHRTL | 171 | Q9UH17 | |
| DDLEKYWDFYHSLFT | 361 | Q9Y574 | |
| DNYWEYLHNSKSFFR | 2141 | Q7Z2Y8 | |
| SHYYVLWDDNRFTAD | 761 | Q9UL18 | |
| ALKKYLFYFERWENH | 361 | O95376 | |
| NTRWKEDIRYHYAEI | 321 | Q6P1R3 | |
| YFLKAIDQYWHEDCL | 41 | P25791 | |
| YDIAKHLTYENVERW | 91 | P62491 | |
| YDIAKHLTYENVERW | 91 | Q15907 | |
| RKTEYALWNYLFAAV | 906 | Q4ADV7 | |
| RLYWLLKNAENEAYF | 791 | O75747 | |
| RWHALSREEQAKYYE | 336 | Q9UJU2 | |
| EEYHLYRENKSASWV | 56 | Q8N149 | |
| AVCYENRLHWFAKYF | 111 | Q8IWT6 | |
| LYRYAAEFLTSWENH | 376 | Q9NW15 | |
| VEFSHERLEEYKWNY | 906 | O75140 | |
| KDSLDWTRHNYYESF | 21 | Q6NYC1 | |
| KQLYHSDEFRAYDWG | 296 | Q5VXI9 | |
| HWFVLADQSLRYYRD | 406 | Q6WCQ1 | |
| YWIAVSHKAPAFLYD | 351 | Q8WVX9 | |
| WFDDYYLKLRPETNH | 336 | P41594 | |
| HFFDRSYDKGLAWYR | 171 | Q9Y662 | |
| IDYVNRRLYWADENH | 3181 | Q9NZR2 | |
| SDVGDYDHVFWYQKR | 46 | A0A075B6J2 | |
| ADRFLLYAMDSYWHS | 31 | P61968 | |
| SLKYYRDTYHPLDDW | 1291 | Q03001 | |
| AVDYHNERLYWADAK | 4051 | Q07954 | |
| VKYWHYVRALDLSFS | 396 | Q8N371 | |
| RQRLEEYFQHAWSYT | 546 | Q9H252 | |
| YRDNAYKDLAWKHGN | 46 | Q96MG8 | |
| HSYSEEEKYAFVNWI | 116 | P13796 | |
| RLAHVWLDEYKEQYF | 401 | Q8NCW6 | |
| FSFLSLDKHREWLEY | 656 | Q9Y2G8 | |
| AEAWHLYNDVYRASQ | 1576 | P09848 | |
| RLLVHFDNWDDSYDY | 221 | Q8NA19 | |
| VNHEYLSFRDKLYWT | 556 | Q96RT7 | |
| HFFDRSYDKGLAWYR | 186 | Q9Y663 | |
| IDYLNNDRIYWSDFK | 4236 | P98164 | |
| FYHDLDPNEAKQWLY | 121 | O43301 | |
| KWYGVRSYLHLFYED | 21 | Q9GZP1 | |
| YWRKCFQTAHFYLED | 1661 | P23471 | |
| YAAMLRIYKHWDFNV | 251 | Q6P4A8 | |
| AQKLHFYDRWAPDYD | 26 | Q8N6F8 | |
| EWRYYFFSLFQKHNE | 61 | Q8TEZ7 | |
| QYAQRDKKHEYWFAV | 581 | Q8N573 | |
| FYEISNWALFRYSAD | 456 | Q9ULV1 | |
| TWRLKENYAAEYANA | 131 | Q1HG44 | |
| AYNAYKAWLRKHGEE | 791 | P0DPD8 | |
| RDYDHSKFWAYADYK | 116 | Q96EW2 | |
| DWAHLYLQRKYNDAL | 291 | Q9UKF2 | |
| SFEYDLRLVLYQHWS | 271 | O75419 | |
| WHSYINFELRYKEVD | 346 | Q9BZJ0 | |
| TLYLRHYWKDERLSF | 121 | P24046 | |
| DERWHYFLVFEKYNK | 196 | O14929 | |
| AEASYRWVRHKYNFD | 1456 | O43497 | |
| RDEDKKNHYNYGWSF | 171 | Q9UBN1 | |
| FHYNEKRIYWVDLER | 81 | P01133 | |
| ITNLYSVHFDEKYWR | 401 | Q6VVX0 | |
| HFWHDVKLRFYYNTS | 171 | Q5JPI3 | |
| IVESYQIRYWAAHDK | 836 | Q12860 | |
| DFEDVLRYDEHAYKW | 126 | O75936 | |
| CASEYLWHAREKAYQ | 11 | A0A1B0GU71 | |
| AIYKWITDNFCYFRH | 146 | Q92949 | |
| NLYAWRPVFDEYDHK | 791 | O60266 | |
| AKTWVRYAEFYSHEA | 381 | O75342 | |
| VTAYIHKDSEWYNLF | 211 | Q8N4S9 | |
| FKLTYYSHWILDDSL | 251 | Q96T53 | |
| LYMDSWARHRIYAAF | 421 | Q12894 | |
| SSVYFKHSYEDWLEN | 26 | O43462 | |
| DIYTWIEDHFPYFKH | 261 | Q08050 | |
| FQYVHEHYLEDADWF | 151 | Q9NS00 | |
| WDHYDNIYITSRFLR | 351 | Q5T1A1 | |
| QSQWLRAYLEAYKEF | 366 | Q9HBU6 | |
| IQDYDLFKQSYWNHR | 661 | Q14839 | |
| WLYDNHKDESYLRRV | 271 | O60832 | |
| HFFDRNYEKGLEWYR | 231 | Q9Y661 | |
| QYWVHYLDHDSLANK | 921 | Q56UN5 | |
| IHFLVYAWDSTYRKF | 96 | P12830 | |
| TLYLRHYWKDERLAF | 101 | P28476 | |
| DNETLWDKLDHYYRI | 41 | Q93100 | |
| NLITWQKVDYDFSYH | 481 | Q9BTE3 | |
| YVDREAHFYWRTKYE | 361 | O15547 | |
| LIDAYAFRIYGHWVK | 346 | Q16816 | |
| DLTQAWDLYYHVFRR | 2096 | P42345 | |
| ELDKDHARYLSYFRW | 321 | Q11128 | |
| QDIWYHEDRIRAKFY | 61 | Q9Y3D9 | |
| RSVNHRYKHFDWLYE | 281 | Q9Y5X1 | |
| NELWRAKYIYDSAFH | 66 | Q9H9B4 | |
| YVDFAEFYRLWSVDH | 481 | Q15750 | |
| FYSYQSLHEWFRDTD | 361 | Q8N0V4 | |
| FKDQLYWRYDDHTRH | 446 | Q9ULZ9 | |
| YKRGHFAELLSYWQF | 896 | Q7Z494 | |
| YAAFKRWHFETLEYF | 156 | Q9UGC7 | |
| HLESWCVQRDKYRYF | 26 | Q9Y6M9 | |
| QFLSAAYDRYLKLWD | 346 | O60508 | |
| IFDDFREAYYWLRHN | 501 | P46977 | |
| ITSNYWKFSDHYFER | 326 | Q9UJ37 | |
| LDWSLDHKIFYYIDS | 156 | Q15493 | |
| IHARKYQYWAVVFES | 41 | Q92535 | |
| LAWRQQLYKLYEADF | 386 | Q9NRB3 | |
| AAKLQDFHQWYLAAY | 356 | Q6IBW4 | |
| DFHQWYLAAYADHAD | 361 | Q6IBW4 | |
| SDDKPTEHYYRLLWF | 176 | Q9NQW8 | |
| EQLAYYHHDWFIFKE | 546 | P51790 | |
| KAEYLLREWVNLYHS | 1851 | A5YKK6 | |
| DDKRYRYAFHSSAWL | 121 | O75333 | |
| FSKGVHYWELHVDRY | 646 | Q6ZTA4 | |
| TENAALTFLWYFYRD | 451 | Q5GH73 | |
| HYYIQASSKAERAEW | 331 | Q9NYT0 | |
| HIEKLFLYSFSWDFE | 346 | Q5W0Q7 | |
| YAAYIIHAYKDKDWV | 756 | O15455 | |
| RRYKHFDWLYARLAE | 311 | Q96RF0 | |
| PWKAAYHHFQRYSDV | 906 | Q9H0E3 | |
| RRWHALSREEQAKYY | 386 | Q9NQB0 | |
| LEEYEEWHQDYRKFR | 861 | Q9UHP3 | |
| KHWDALFSYVERFFS | 636 | O94876 | |
| SYKYNEWADDRRHLG | 271 | Q92620 | |
| LRYSWYKNHVLLEDA | 356 | Q9BZZ2 | |
| RWHALSREEQAKYYE | 306 | P36402 | |
| ISFNFWYRLGEHLYK | 341 | Q9Y5L0 | |
| DYHFWEEFYSKALGR | 226 | Q6UWM9 | |
| TARWYLLRHLYAKDD | 1521 | Q6PGP7 | |
| DDKRYRYAFHSSSWL | 166 | O43435 | |
| WIFRLWYSFDHNYLK | 596 | Q96T83 | |
| ELYQSARAWKDHKAY | 631 | Q8IWU6 | |
| ADYWSNYEFHNRVIF | 1831 | O60293 | |
| RWVLKFYFHEALRAF | 96 | Q15554 | |
| DLHSRNYLYDRSLWN | 146 | Q96DZ7 | |
| YLSDEHGKCRKSFYW | 141 | Q4V348 | |
| RAYWNASDLRYKETF | 5256 | P20929 |